Idera Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Aceragen

09/11/2021 24:01

* Idera Pharmaceuticals Inc  IDRA.OQ  reported a quarterly
adjusted loss of 11 cents​​ per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 12 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Idera Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 11 cents​.
* The mean earnings estimate of analysts had risen by
about 32.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Idera Pharmaceuticals Inc shares had fallen by 17.6% this
quarter and lost 76.9% so far this year.
* The company reported a quarterly loss of $5.97 million.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 12:01 a.m.
 ​All figures in US dollars unless otherwise stated